← Leaderboards
Vincent Jo Davisson
Purdue University West Lafayette
$8,621,330
Attributed
$10,833,656
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,833,656 · 11
By mechanism
R01$4,947,946 · 3
U54$2,136,738 · 2
R33$1,250,763 · 1
UG3$1,150,119 · 1
R21$868,157 · 3
P30$479,933 · 1
Top collaborators
- Robert A Davey4 shared
- Joseph Paul Robinson3 shared
- Eric L Barker2 shared
- Tony Hazbun1 shared
Most similar at Purdue University West Lafayette
Same institution · by research overlap
- Eric L Barker$3,289,865
- Janet L Smith$23,647,105
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseIn VitroIn VivoDesignAnimal ModelLeadUniversitiesEvaluationPharmacologic SubstanceResearch PersonnelMetabolicChemistryMolecularPre-ClinicalIn Vivo ModelDrug KineticsStagingToxic EffectCellsTranslationsFormulationPharmaceutical ChemistryEnsureLead Candidate
Grant awards (32)
Platinum Based Countermeasures and Combinations with Protective Agents$559,817
UG3 · FY2025 · NS · contact PI
Platinum Based Countermeasures and Combinations with Protective Agents$590,302
UG3 · FY2024 · NS · contact PI
Pharmaceutical Sciences Core$388,093
U54 · FY2023 · NS · contact PI
Antiviral Lead Identification to Treat Filovirus Infections$637,035
R01 · FY2022 · AI · contact PI
Pharmaceutical Sciences Core$538,085
U54 · FY2022 · NS · contact PI
Antiviral Lead Identification to Treat Filovirus Infections$621,031
R01 · FY2021 · AI · contact PI
Pharmaceutical Sciences Core$364,227
U54 · FY2021 · NS · contact PI
Antiviral Lead Identification to Treat Filovirus Infections$704,383
R01 · FY2020 · AI · contact PI
Pharmaceutical Sciences Core$410,248
U54 · FY2020 · NS · contact PI
Antiviral Lead Identification to Treat Filovirus Infections$639,566
R01 · FY2019 · AI · contact PI
Pharmaceutical Sciences Core$436,085
U54 · FY2019 · NS · contact PI
Developmental Molecular Discovery and Evaluation$108,612
P30 · FY2014 · CA · contact PI
Developmental Molecular Discovery and Evaluation$79,372
P30 · FY2013 · CA · contact PI
Specific Detection of Cervical Cancers Using Cytometry-Based Molecular Diagnostic$404,913
R33 · FY2012 · CA
Developmental Molecular Discovery and Evaluation$90,593
P30 · FY2012 · CA · contact PI
Specific Detection of Cervical Cancers Using Cytometry-Based Molecular Diagnostic$414,004
R33 · FY2011 · CA
Developmental Molecular Discovery and Evaluation$98,345
P30 · FY2011 · CA · contact PI
Specific Detection of Cervical Cancers Using Cytometry-Based Molecular Diagnostic$431,846
R33 · FY2010 · CA
Lipidomic profile of endocannabinoids from neuronal cells$190,625
R21 · FY2010 · DA
Developmental Molecular Discovery and Evaluation$103,011
P30 · FY2010 · CA · contact PI
Lipidomic profile of endocannabinoids from neuronal cells$228,750
R21 · FY2009 · DA
High-throughput Chemotyping of Yeast Signature Strains Reflecting Hsp90 Biology$152,500
R21 · FY2007 · NS
Modified Nucleosides as Tools for Molecular Biology$328,455
R01 · FY2006 · GM · contact PI
Structures and Mechanisms of Glutamine Dependent Enzymes$250,172
R01 · FY2006 · GM · contact PI
Modified Nucleosides as Tools for Molecular Biology$336,713
R01 · FY2005 · GM
Structures and Mechanisms of Glutamine Dependent Enzymes$256,522
R01 · FY2005 · GM
Modified Nucleosides as Tools for Molecular Biology$337,044
R01 · FY2004 · GM
Structures and Mechanisms of Glutamine Dependent Enzymes$256,854
R01 · FY2004 · GM
Modified Nucleosides as Tools for Molecular Biology$302,513
R01 · FY2003 · GM
Structures and Mechanisms of Glutamine Dependent Enzymes$277,658
R01 · FY2003 · GM
Enzyme Targets, Apoptosis and Purine Metabolism$147,806
R21 · FY2002 · CA
Enzyme Targets, Apoptosis and Purine Metabolism$148,476
R21 · FY2001 · CA